Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • TUV Rheinland India...

    TUV Rheinland India enter partnership with Andhra Pradesh MedTec Zone to deliver medical devices

    Written by Ruby Khatun Khatun Published On 2017-06-19T09:26:29+05:30  |  Updated On 19 Jun 2017 9:26 AM IST

    Hyderabad: TUV Rheinland India, a subsidiary of TUV Rheinland Group, Germany, a worldwide leader in Testing, Training, Inspection, Consulting and Certification, announced that it has partnered with Andhra Pradesh MedTech Zone(AMTZ), the country’s first Medical Technology Manufacturing Park.


    AMTZ was recently established at Visakapatnam over an area of 270 acres by the Government of Andhra Pradesh.


    As per the terms of the partnership, TUV Rheinland India has been awarded a contract to set up and operate Electro-Magnetic Interference (EMI/EMC) including Anechoic Chambers, Biomaterial, Reliability and Electrical Safety Testing Facilities on Public Private Partnership Mode within AMTZ at an estimated investment of about Rs 85 crore over 4-5 years to support AMTZ’s objective to reduce medical device imports and production cost, partner with industry to deliver the quality medical devices to local market and eventually increase the export of world class medical devices to the international market, a release said here.


    The contract was signed by Mr. Thomas Fuhrmann, Managing Director of TUV Rheinland India and Dr.Jitendar Kumar Sharma, Director and CEO of AMTZ.
    The creation of AMTZ is based on the fact that medical devices manufacturing requires very high investment facilities which are capital intensive for individual manufacturers to invest upon.


    With a market size of close to 4 Billion dollars,78 per cent of medical devices in India are imported from other countries, the release said.


    AMTZ will house modern 250-300 independent manufacturing units,each over a built-in ready to use area at a very cost effective long-term lease.


    In addition, the park will have in-house high investment scientific facilities, including state-of-the-art testing laboratories, which would help manufacturers significantly reduce the cost manufacturing thereby creating world class diagnosis with quality products accessible to the common man at affordable prices.

    AMTZAndhra PradeshAndhra Pradesh MedTec ZoneDr Jitendar Kumar SharmaElectro Magnetic InterferenceMedical Devicesmedical devices parkMedical Technology Manufacturing ParkpartnershipThomas FuhrmannTUV Rheinland GroupTUV Rheinland IndiaVisakapatnam
    Source : UNI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok